| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
122,563,000 |
| Market
Cap: |
6.61(B) |
| Last
Volume: |
8,264,325 |
Avg
Vol: |
8,242,049 |
| 52
Week Range: |
$26.88 - $108.06 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
138,093 |
288,980 |
461,958 |
926,280 |
| Total Sell Value |
$8,135,395 |
$19,867,810 |
$25,677,895 |
$46,442,456 |
| Total People Sold |
7 |
8 |
8 |
12 |
| Total Sell Transactions |
11 |
21 |
41 |
87 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rabson Michael |
SVP Business Dev/Legal & GCOff |
• – – |
2008-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,293 |
|
- |
|
| Spudich James A |
Director |
– • – |
2008-03-20 |
4 |
AS |
$3.38 |
$6,761 |
D/D |
(2,000) |
182,600 |
|
- |
|
| Spudich James A |
Director |
– • – |
2008-02-27 |
4 |
AS |
$3.50 |
$7,000 |
D/D |
(2,000) |
184,600 |
|
- |
|
| Spudich James A |
Director |
– • – |
2008-01-08 |
4 |
AS |
$4.51 |
$13,546 |
D/D |
(3,000) |
186,600 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-12-14 |
4 |
AS |
$5.39 |
$36,124 |
D/D |
(6,702) |
31,220 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-12-14 |
4 |
OE |
$2.00 |
$13,404 |
D/D |
6,702 |
37,922 |
|
- |
|
| Spudich James A |
Director |
– • – |
2007-12-10 |
4 |
AS |
$5.62 |
$16,883 |
D/D |
(3,000) |
189,600 |
|
- |
|
| Sabry James H |
Executive Chairman |
• • – |
2007-12-03 |
4 |
AS |
$5.00 |
$35,000 |
D/D |
(7,000) |
0 |
|
- |
|
| Sabry James H |
Executive Chairman |
• • – |
2007-12-03 |
4 |
OE |
$1.20 |
$8,400 |
D/D |
7,000 |
7,000 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-11-30 |
4 |
AS |
$5.19 |
$35,318 |
D/D |
(6,805) |
31,220 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-11-30 |
4 |
OE |
$2.00 |
$13,610 |
D/D |
6,805 |
38,025 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-11-15 |
4 |
AS |
$5.00 |
$35,045 |
D/D |
(7,009) |
31,220 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-11-15 |
4 |
OE |
$2.00 |
$14,018 |
D/D |
7,009 |
38,229 |
|
- |
|
| Spudich James A |
Director |
– • – |
2007-11-02 |
4 |
AS |
$5.17 |
$15,523 |
D/D |
(3,000) |
192,600 |
|
- |
|
| Sabry James H |
Executive Chairman |
• • – |
2007-11-01 |
4 |
AS |
$5.00 |
$35,000 |
D/D |
(7,000) |
0 |
|
- |
|
| Sabry James H |
Executive Chairman |
• • – |
2007-11-01 |
4 |
OE |
$1.20 |
$8,400 |
D/D |
7,000 |
7,000 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-10-31 |
4 |
AS |
$5.00 |
$37,123 |
D/D |
(7,419) |
31,220 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-10-31 |
4 |
OE |
$2.00 |
$14,838 |
D/D |
7,419 |
38,639 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-10-15 |
4 |
AS |
$5.98 |
$49,810 |
D/D |
(8,237) |
38,720 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-10-15 |
4 |
OE |
$2.00 |
$16,474 |
D/D |
8,237 |
46,957 |
|
- |
|
| Spudich James A |
Director |
– • – |
2007-10-03 |
4 |
AS |
$5.41 |
$16,232 |
D/D |
(3,000) |
195,600 |
|
- |
|
| Sabry James H |
Executive Chairman |
• • – |
2007-10-01 |
4 |
AS |
$5.00 |
$35,195 |
D/D |
(7,000) |
0 |
|
- |
|
| Sabry James H |
Executive Chairman |
• • – |
2007-10-01 |
4 |
OE |
$1.20 |
$8,400 |
D/D |
7,000 |
7,000 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-09-28 |
4 |
AS |
$5.09 |
$50,259 |
D/D |
(9,874) |
38,720 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2007-09-28 |
4 |
OE |
$2.00 |
$19,748 |
D/D |
9,874 |
48,594 |
|
- |
|
1115 Records found
|
|
Page 36 of 45 |
|
|
0.38 (0.71%) 
